User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.67% 147.50 145.00 150.00 149.50 147.50 149.50 68,911 16:09:39
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 6.1 -13.9 -35.9 - 84

Reneuron Share Discussion Threads

Showing 8051 to 8073 of 8300 messages
Chat Pages: 332  331  330  329  328  327  326  325  324  323  322  321  Older
DateSubjectAuthorDiscuss
01/12/2020
19:14
I have re-read the interim report and would like to ask the posters here for your understanding on the cash. (1) 30 Sep 2020 cash was £9.8m (no question on that) (2) £17.5m from Placing & Fundraise. Estimated £1m costs leaving £16.5m (roughly correct?) (3) Cash burn - this is where I realised I may have mis-read. See below: The interim states "Fundraise..to extend the Company's cash runway for at least the period of 18 months". That suggests an extra 18 months from the £16.5m which indicates that the company's estimated cash burn is £16.5m/18, a cash burn of £0.92m per month (4) 2 months has passed so original £9.8m will now be (£9.8m-1.84m) which is £7.96m (round to £8m) (5) Also Fosun agreement April 2019, Fosun will be paying up to £6m in near-term operational milestones. (so allow £3m over next 18 months). Note 19 months already passed since agreement. Cash ahead: £8m (original cash) + £16.5m (fundraise) + £3m (Fosun cash next 18 months) = £27.5m Total cash runway: £27.5m / £0.92m per month = 30 months, 2.5 years. So cashed for "at least" 10 quarters. Your thoughts pos and neg appreciated.
parc1
30/11/2020
23:35
Recent Exosome IPO in the US Codiak (CDAK) topping the Biotech sector leader board on US markets today htTps://twitter.com/bradloncar/status/1333533590370603018?s=20
the stigologist
28/11/2020
22:09
Pleased that I'll have a chance to fund this Company's research and development after reading that
the stigologist
28/11/2020
20:35
Interesting piece about a sufferer from retinitis pigmentosa. About time someone had a treatment for that... https://www.bbc.co.uk/news/health-55045487
supernumerary
26/11/2020
12:28
Got my e-mail re entitlement take up yesterday. Taking up full allocation and bidding for more. I expect it will be significantly over subscribed.
the stigologist
25/11/2020
22:07
Bullish engulfing candle + Gap to fill Lots of news to come in H1 2021 on Preclinical trials as well from 3 Bio/Pharma partnerships on Exosomes
the stigologist
25/11/2020
12:09
That's more like it.
small crow
25/11/2020
08:58
think he is over on lse
martinfrench
24/11/2020
16:57
Should have said “Freddy still visit this board”
hsbilkhu
24/11/2020
16:56
Does Freddy with visit these boards I remember he used to have a large holding years ago
hsbilkhu
24/11/2020
11:11
That's great info Timbo ... going to print it out for future reference ... thanks.
pedr01
24/11/2020
09:55
>>>az4hr Sorry, I missed that, so I will try to answer here: If a company is going to issue EIS/VCT qualifying shares it will generally (but not always) have obtained advanced approval from HMRC and your broker should know this. So for example, if you look at the book building announcement yesterday (hit control f to search EIS) you will see that some of the shares qualified for EIS https://www.investegate.co.uk/reneuron-group-plc--rene-/rns/proposed-placing--subscription-and-open-offer/202011231742442393G/ It is not unusual for a company to issue both EIS qualifying and non-qualifying shares in the same fund raising round, this is because EIS cash can only be spent of certain activities (growth capital), it cannot be used for activities such as acquisitions, so if a fund raise is for the purposes of an acquisition and to invest in organic growth, it will not be all EIS qualifying. If a placing opportunity does come along, always ask the broker to confirm if any of the shares qualify for EIS and always stipulate that you only wish to be issued with EIS shares. I would recommend that you check with the broker on a one or two monthly basis to see how the process of obtaining your (necessary) EIS3 certificates is coming along. Obtaining the certificates is a clunky process, it can take a while and can get held up for all sorts of reasons, but if you have someone chase it up on a regular basis, you still generally receive the EIS3 certificate within 3 – 9 months. I would say my success rate for obtaining EIS3 certificates is around 90%. You need the EIS3 certificate to make a claim to HMRC for an income tax refund, without an EIS3 certificate you will definitely not get a refund
timbo003
24/11/2020
09:53
what broker do you use timbo please
az4hr
24/11/2020
09:45
Rayrac is here hTTps://josepthsheedy.wordpress.com/2020/11/18/rayrac/
slartybartfaster
24/11/2020
08:37
anybody seen rayrac loooooooooooooooooooooooooooooooooooooooooooooool
manc10
24/11/2020
08:37
Shareholders subscribing for their full entitlement under the Open Offer may also request additional Open Offer Shares through the Excess Application Facility.
onceaday
24/11/2020
08:37
>>>>>az4hr/algernon I first heard about this one yesterday lunch time, there was an accelerated bookbuild announced after the close yesterday, so it should have been possible for anyone with a decent boker to participate. There is some good looking chap talking to Tamsin on PIworld about how to get into these sort of placings here, if you have a few minutes to spare 😉 https://www.youtube.com/watch?v=6XQOtwcnKkU
timbo003
24/11/2020
08:21
Yes how did you get notified Timbo as I have only heard of this via the BB today and yesterday and have heard nothing via Nominee account provider so assumed the offer wasn;t for everyone to be involved in..
algernon2
24/11/2020
08:15
How did you get your allocation timbo. Don't really understand placing and open offers. Would have been more than willing to get some shares in a placing
az4hr
24/11/2020
08:10
I was fortunate enough to pick up a few in the placing, surprisingly my modest application (for EIS shares) was not scaled back, although non-EIS applications were scaled back to around 40% Usually it's the other way around and 70p/share is a very attractive entry price, so I'm rather pleased about that.
timbo003
23/11/2020
22:34
I do not like this type of issue. They could have raised the same amount witha 4 for 5 issue. Doubtless, Schroders weren't interested. We get 1 for 9 which, given last night's bid price of 91p gives us an average of 88.9p. However, the total issue will represent 43.9% of the new outstanding shares giving a "right price" of 81.78p tomorrow morning. It's no surprise that the Dirctors are snapping up 1.5 million. They have 17% updside to the "right price". Hopefully, they are expecting a lot more than that.
dickbush
23/11/2020
20:02
It refers to ‘Major Shareholdings’ on the website when I presume they mean ‘Shareholders’. More cash from the Welsh government?
semper vigilans
23/11/2020
19:58
Careful aren't they, these PR types....
small crow
Chat Pages: 332  331  330  329  328  327  326  325  324  323  322  321  Older
ADVFN Advertorial
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210509 16:30:57